SCHEMBL6792350

SCHEMBL6792350

O=C(O)c1c2c(nn1CCCNCCc1cccs1)-c1ccncc1CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.42
KDM4C Q9H3R0 1/20 0.35
NAMPT P43490 2/20 0.34
ADAM17 P78536 7/20 0.34
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
CHEK1 O14757 1/20 0.32
DAPK3 O43293 1/20 0.32
MAP4K4 O95819 1/20 0.32
PIM1 P11309 1/20 0.32
PRKACA P17612 1/20 0.32
KDR P35968 1/20 0.32
MAP2K2 P36507 1/20 0.32
MAPK8 P45983 1/20 0.32
CSNK1A1 P48729 1/20 0.32
CDK8 P49336 1/20 0.32
CLK2 P49760 1/20 0.32
GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4257701 0.95 ROCK2 (0.39) ROCK2KDM4CNAMPTADAM17KDM4E
Trifluoroacetic Acid SCHEMBL1658074 0.88 ROCK2 (0.37) ROCK2KDM4CNAMPTKDM4EALDH1A1
SCHEMBL4257707 0.87 ROCK2 (0.38) ROCK2NAMPTKDM4ENPC1ALDH1A1
SCHEMBL6791734 0.86 ROCK2 (0.41) ROCK2KDM4CNAMPTADAM17MAPT
Trifluoroacetic Acid SCHEMBL6793066 0.86 ROCK2 (0.38) ROCK2KDM4ENPC1ALDH1A1MAPT
Hydrochloric Acid SCHEMBL1656611 0.84 ROCK2 (0.35) ROCK2KDM4CNAMPT
SCHEMBL1656621 0.83 CCNA2 (0.36) ADAM17KDM4ENPC1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL4270585 0.83 CDK2 (0.33) ROCK2NAMPTKDRPDPK1CDK2
SCHEMBL5484987 0.83 ROCK2 (0.34) ROCK2NAMPTPDPK1CDK2
Trifluoroacetic Acid SCHEMBL6787470 0.83 ALDH1A1 (0.36) ROCK2NAMPTKDM4ENPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 PHARMACIA CORPORATION 2004-07-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127492-A1 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 MKNK2, MAPKAPK2, MAP3K2 ROCK2 317/4885KDM4C 3390/4885NAMPT 658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.